Pharmaceutical Executive: March 2023

Navigating Disruption in the Metapharma Era

March 10, 2023

Feature

43

3

As the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.

Biopharma M&A: Year in Review, Ripples Ahead

March 10, 2023

Features

43

3

While industry financial markets continued to experience subdued dollar volumes in 2022, dealmaking held steady—with factors such as pharma pursuing strategic priorities and biotech funding woes playing major roles.

Being KOL-Centric: More Meaningful Expert Engagement

March 10, 2023

Features

43

3

Global medical affairs teams seek better support to manage relationships with key opinion leaders—and find that balance between patient needs, scientific objectives, and the interest areas of KOLs.

A New Era of Influence: Embracing the KOL-DOL Dynamic in Healthcare

March 10, 2023

Features

43

3

How pharma companies can leverage the lessons learned during the pandemic around key opinion leaders and digital opinion leaders, respectively, to best use new channels of communication. Can both coexist across the healthcare engagement spectrum?

The Pivot to Digital

March 10, 2023

Executive Profile

43

3

Chronicling Davidek Herron’s career crossover from playing professional basketball to leading Roche’s digital transformation and scale-up efforts—and the team lessons learned along the way.